Brief: Editas Medicine - On March 8, James C. Mullen Notified Board That He Does Not Intend To Seek Re-Election At 2023 Annual Meeting
March 14 (Reuters) - Editas Medicine Inc EDIT.O :
* EDITAS MEDICINE - ON MARCH 8, JAMES C. MULLEN NOTIFIED
BOARD
THAT HE DOES NOT INTEND TO SEEK RE-ELECTION AT 2023 ANNUAL
MEETING
Source text: [ID:https://m5.gs/Y09ZcE]
Further company coverage: EDIT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Editas Medicine
See all newsEditas Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary
Editas Medicine, Inc. expected to post a loss of 27 cents a share - Earnings Preview
Editas Medicine Q2 net loss narrows and beats estimates
Brief: Editas Medicine Q2 Net Income USD -18.23 Million Vs. IBES Estimate USD -27 Million
Editas Medicine down after $125 mln stock-and-warrants offering